Miscellaneous Musculoskeletal Disorders

Positive Results for Xiaflex in MULTICORD Study

BioSpecifics Technologies has announced positive results from its Phase 3b MULTICORD study evaluating Xiaflex (collagenase clostridium histolyticum) for the concurrent treatment of adult Dupuytren’s contracture patients with multiple palpable cords.